Spectrum Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.46M Sell
51,852
-129
-0.2% -$3.69K 0.57% 63
2015
Q4
$1.59M Sell
51,981
-212
-0.4% -$6.67K 0.64% 57
2015
Q3
$1.55M Buy
52,193
+289
+0.6% +$9.27K 0.65% 54
2015
Q2
$1.65M Sell
51,904
-6,593
-11% -$215K 0.63% 57
2015
Q1
$1.93M Hold
58,497
0.68% 53
2014
Q4
$1.73M Hold
58,497
0.6% 54
2014
Q3
$1.64M Sell
58,497
-1,115
-2% -$31.3K 0.59% 57
2014
Q2
$1.68M Hold
59,612
0.58% 58
2014
Q1
$1.82M Sell
59,612
-959
-2% -$28.6K 0.65% 51
2013
Q4
$1.76M Buy
60,571
+756
+1% +$22K 0.62% 53
2013
Q3
$1.63M Sell
59,815
-1,370
-2% -$37.3K 0.63% 53
2013
Q2
$1.63M Buy
+61,185
New +$1.69M 0.66% 51

Other funds holding PFE

Spectrum Advisory Services's PFE Position: Q1 2016 in Review

Spectrum Advisory Services reduced its Pfizer (PFE) stake by 0.25% in Q1 2016, selling an estimated $3.69K and leaving 51,852 shares worth $1.46M. The position accounts for 0.57% of the portfolio, ranked #63.

Spectrum Advisory Services first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.93M in Q1 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Spectrum Advisory Services held 51,852 shares of Pfizer worth $1.46M as of Q1 2016.
  • Spectrum Advisory Services sold 129 Pfizer shares in Q1 2016, an estimated $3.69K.
  • Pfizer made up 0.57% of Spectrum Advisory Services's portfolio in Q1 2016, its #63 holding.
  • Spectrum Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
  • Spectrum Advisory Services's Pfizer position peaked at $1.93M in Q1 2015.
  • 1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.